Try our beta test site
1 study found for:    8717514 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Ipilimumab in the Immune System
Condition: Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
Intervention: Drug: Ipilimumab at 3 mg/kg dose

Study has passed its completion date and status has not been verified in more than two years.